From post

Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa.

, , , , , , , , и . BMC Syst. Biol., 12 (1): 66:1-66:10 (2018)